In Vivo Gene Delivery Using piggyBac With Hydrodynamic Tail Vein Injection
The piggyBac (PB) transposon system, originally identified in the Cabbage [...]
Fine Needle Aspirate Serial Tumor Sampling Services To Boost Your Xenograft Study Capabilities
Xenograft tumors from human cancer cell lines in immunocompromised mice are [...]
Validation Of The SRG Rat For Human Tumor Studies Published In PLOS ONE
We Are Excited To Announce That A Validation Study Using [...]
Gene Editing With piggyBac: Creating A Curative Treatment For Beta-Thalassemia
Genetic Engineering Can Soon Lead To Lifelong Cures For Diseases [...]
HepG2-CYP Cell Panel – Case Study
Engineered HepG2 Cells for Assessing CYP Mediated Metabolism [...]
OncoRat® Featured In Clinical Cancer Research For Prostate Cancer Studies
Improving Preclinical Anticancer Studies Using Rat Xenograft Model Systems: A Case [...]
The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells
Ovarian cancer is the most lethal gynecological cancer in the [...]
H358 NSCLC Xenografts In Humanized Rats: The Ideal In Vivo Model For Studying KRAS Mutations
Lung adenocarcinomas, the major histological subtype of non-small cell lung [...]
Hera Biolabs Announces Molecular Cancer Therapeutics Publication On Immunodeficient Rats For Oncology Research
Hera Biolabs, the University of Michigan, Case Western Reverse University and other collaborators are announcing a recent publication in the American Association for Cancer Research (AACR) journal, Molecular Cancer Therapeutics, entitled, "Sprague Dawley Rag2-null rats created from engineered spermatogonial stem cells are immunodeficient and permissive to human xenografts."
Breakthroughs In Gene Editing Allow For The Creation Of Superior Preclinical Oncology Models
Gene editing is getting a lot of attention in the [...]